Compare BNTC & KBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | KBON |
|---|---|---|
| Founded | 1995 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 442.4M |
| IPO Year | 2020 | N/A |
| Metric | BNTC | KBON |
|---|---|---|
| Price | $13.60 | $10.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 96.8K | 21.4K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $10.04 |
| 52 Week High | $17.15 | $10.15 |
| Indicator | BNTC | KBON |
|---|---|---|
| Relative Strength Index (RSI) | 73.81 | 59.30 |
| Support Level | $12.79 | $10.05 |
| Resistance Level | $14.13 | $10.11 |
| Average True Range (ATR) | 0.73 | 0.02 |
| MACD | 0.32 | 0.00 |
| Stochastic Oscillator | 94.28 | 50.00 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Karbon Capital Partners Corp is a blank check company.